According to a new market report published by Lucintel, the future of the metagenomic market looks promising with opportunities in applications, such as infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, and agriculture. The global metagenomic market is expected to grow with a CAGR of 17% from 2020 to 2025. The major drivers for this market are surge in the metagenomic experiment collaboration, adoption of metagenomic applications, and growing advanced sequencing platforms.
To download report brochure, please go to https://www.lucintel.com/metagenomic-market.aspx and click "download brochure" tab from the menu
Metagenomics is a study of microbial communities where we can't separate one microbe from another. In this market, instrument & software and consumables are the major product segments. Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to their high adoption in the pre-sequencing, which is one of the most important steps in the overall metagenomic sequencing protocol. Therefore, this factor continues to contribute to the dominant position of this segment in the market.
Within this market, gut microbe characterization will remain the largest application type segment over the forecast period. The human intestinal microbiota is a homeostatic ecosystem, which has a significant impact on human health, and the disruption of this equilibrium leads to increased susceptibility to infections by various pathogens.
North America will remain the largest region over the forecast period due to increasing implementation of DNA sequencing across metagenomic applications in this region. In addition, rapid adoption of novel sequencing technologies in this region has contributed to its dominance.
Agilent Technologies, Enterome, F. Hoffmann-La Roche., Illumina, Oxford Nanopore Technologies, Pacific Biosciences of California, PerkinElmer, Qiagen, Swift Biosciences, and Thermo Fisher Scientific are among the major suppliers in the global metagenomic market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global metagenomic market by product, technology, application, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Metagenomic Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global metagenomic market by product, technology, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Instrument & Software
Consumables
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Sequencing
Bioinformatics
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Infectious Disease Diagnosis
Environmental Remediation
Gut Microbe Characterization
Biotechnology
Biofuel
Agriculture
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
Spain
Italy
France
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.